BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20150308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20151101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20161013T120000
DTEND;TZID=America/New_York:20161013T130000
DTSTAMP:20260406T031341
CREATED:20161013T160000Z
LAST-MODIFIED:20190307T202238Z
UID:10000815-1476360000-1476363600@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, John B. Buse "Type 2 Diabetes Care: Struggle\, Progress and the Future"
DESCRIPTION:Type 2 diabetes is a major and growing contributor to poor health outcomes globally. Clinical science has conclusively demonstrated that glycemic control reduces the risk of microvascular complications – eye\, kidney and nerve disease. For cardiovascular disease\, blood pressure and lipid management\, smoking cessation and antiplatelet therapies are effective in reducing risk. However\, great controversy regarding the utility of glycemic management to reduce cardiovascular disease has persisted. Further\, treatment with insulin – the mainstay of late diabetes care – has been associated with increasing concerns about hypoglycemia and its impact on health outcomes and quality of care.  Dr. Buse will review major trials published over the last 18 months that have revolutionized the landscape of type 2 diabetes care and suggest a new path forward to reduce the morbidity and mortality associated with the diabetes epidemic. \nDr. Buse’s practice combines clinical care\, research and education. He has received international recognition for innovative efforts at prevention of type 1 diabetes\, type 2 diabetes and their complications. He practices patient-centered care focusing on developing treatment programs in collaboration with patients that meet their needs and expectations. He works with teams of investigators in diabetes clinical trials\, comparative effectiveness research and translation of basic science research towards clinical application. Current projects focus in novel treatments including development of glucose-responsive insulin\, cardiovascular safety and efficacy of diabetes drugs and developing the evidence-base for treatment guidelines of the future in diabetes care. \nDr. Buse is Chief of the Division of Endocrinology\, Director of the NC Translational and Clinical Sciences Institute\, Director of the Diabetes Center and is the Executive Associate Dean for Clinical Research at the University of North Carolina School of Medicine. He has clinical practices at the UNC Highgate Specialty Center in Durham\, NC and the Salem Center in Winston-Salem\, NC. He enjoys lecturing about diabetes.
URL:https://www.med.unc.edu/medicine/event/oct-13/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2019/02/john-b-buse-md-1.jpeg
END:VEVENT
END:VCALENDAR